T1	disease_or_phenotypic_feature 44 51	obesity
T2	disease_or_phenotypic_feature 109 116	obesity
T3	corrected_chemical 118 125;140 164	ghrelin partial inverse agonists
T4	chemical 126 136	antagonist
T5	chemical 156 164	agonists
T6	disease_or_phenotypic_feature 207 214	obesity
T7	disease_or_phenotypic_feature 216 233	Neurofibromatosis
T8	chemical 259 266	biology
T9	chemical 297 311	growth hormone
T10	disease_or_phenotypic_feature 405 418	short stature
T11	disease_or_phenotypic_feature 420 427	obesity
T12	disease_or_phenotypic_feature 433 450	diabetes mellitus
T13	chemical 452 459	Hormone
T14	disease_or_phenotypic_feature 460 469	dependent
T15	chemical 529 537	hormones
T16	chemical 618 626	hormones
T17	disease_or_phenotypic_feature 631 638	obesity
T18	disease_or_phenotypic_feature 699 714	pulmonary edema
T19	disease_or_phenotypic_feature 721 726	hyper
T20	chemical 758 763	ether
T21	chemical 764 774	anesthesia
T22	chemical 783 787	food
T23	disease_or_phenotypic_feature 804 811	obesity
T24	disease_or_phenotypic_feature 865 871	cancer
T25	disease_or_phenotypic_feature 872 876	pain
T26	corrected_chemical 886 904	0.125% bupivacaine
T27	chemical 967 971	drug
T28	chemical 972 981	cisplatin
T29	disease_or_phenotypic_feature 1045 1058	breast cancer
T30	chemical 1060 1079	Alpha 1-antitrypsin
T31	chemical 1106 1113	antigen
T32	disease_or_phenotypic_feature 1154 1167	breast cancer
T33	chemical 1169 1181	Sex hormones
T34	disease_or_phenotypic_feature 1197 1209	liver tumors
T35	chemical 1223 1230	Hormone
T36	disease_or_phenotypic_feature 1231 1240	dependent
T37	chemical 1302 1313	biochemical
T38	chemical 1328 1340	folinic acid
T39	chemical 1345 1357	fluorouracil
T40	chemical 1361 1372	gemcitabine
T41	disease_or_phenotypic_feature 1402 1414	malignancies
T42	chemical 1428 1434	sodium
T43	chemical 1436 1445	potassium
T44	chemical 1450 1455	water
T45	disease_or_phenotypic_feature 1486 1499	heart failure
T46	disease_or_phenotypic_feature 1535 1544	pituitary
T47	chemical 1545 1559	growth hormone
T48	chemical 1587 1599	GABA-agonist
T49	chemical 1600 1609	progabide
T50	disease_or_phenotypic_feature 1614 1624	spasticity
T51	disease_or_phenotypic_feature 1628 1646	multiple sclerosis
T52	chemical 1682 1692	fluoxetine
T53	chemical 1697 1707	sertraline
T54	chemical 1768 1778	fluoxetine
T55	disease_or_phenotypic_feature 1783 1790	obesity
T56	chemical 1862 1872	biomarkers
T57	chemical 1920 1930	everolimus
T58	disease_or_phenotypic_feature 1955 1973	endometrial cancer
T59	chemical 1975 1981	Leptin
T60	chemical 1988 1995	hormone
T61	disease_or_phenotypic_feature 2015 2022	obesity
T62	corrected_chemical 2084 2094;2096 2111	cinacalcet 60 mg/d or more
T63	chemical 2118 2122	drug
T64	disease_or_phenotypic_feature 2185 2198	hypercalcemia
T65	disease_or_phenotypic_feature 2202 2218	hypophosphatemia
T66	corrected_chemical 118 136	ghrelin antagonist
R1	treats Arg1:T66 Arg2:T6	
R2	treats Arg1:T3 Arg2:T6	
T67	missed_disease_or_phenotypic_feature 470 476	tumors
R3	causes_or_contributes_to Arg1:T13 Arg2:T67	
T68	corrected_disease_or_phenotypic_feature 693 714	acute pulmonary edema
R4	causes_or_contributes_to Arg1:T20 Arg2:T68	
T69	corrected_disease_or_phenotypic_feature 865 876	cancer pain
R5	treats Arg1:T26 Arg2:T69	
T70	chemical 893 904	bupivacaine
T71	missed_disease_or_phenotypic_feature 1021 1034	solid tumours
T72	corrected_chemical 952 971	Antineoplastic drug
R6	treats Arg1:T72 Arg2:T71	
R7	treats Arg1:T28 Arg2:T71	
R8	treats Arg1:T72 Arg2:T29	
R9	treats Arg1:T28 Arg2:T29	
T73	missed_disease_or_phenotypic_feature 1241 1269	tumors of the adrenal cortex
R10	causes_or_contributes_to Arg1:T35 Arg2:T73	
T74	corrected_disease_or_phenotypic_feature 1390 1414	solid tumor malignancies
R11	treats Arg1:T38 Arg2:T74	
R12	treats Arg1:T39 Arg2:T74	
R13	treats Arg1:T40 Arg2:T74	
T75	corrected_chemical 1535 1559	pituitary growth hormone
T76	missed_disease_or_phenotypic_feature 1501 1511	Acromegaly
R14	causes_or_contributes_to Arg1:T75 Arg2:T76	
T77	missed_chemical 1561 1563	GH
R15	causes_or_contributes_to Arg1:T77 Arg2:T76	
R16	treats Arg1:T48 Arg2:T50	
R17	treats Arg1:T49 Arg2:T50	
R18	treats Arg1:T48 Arg2:T51	
R19	treats Arg1:T49 Arg2:T51	
T78	corrected_disease_or_phenotypic_feature 1934 1973	metastatic recurrent endometrial cancer
R20	treats Arg1:T57 Arg2:T78	
T79	missed_disease_or_phenotypic_feature 1902 1907	tumor
R21	treats Arg1:T57 Arg2:T79	
T80	corrected_chemical 2084 2103	cinacalcet, 60 mg/d
R22	treats Arg1:T80 Arg2:T64	
T81	chemical 2084 2094	cinacalcet
R23	treats Arg1:T62 Arg2:T64	
R24	treats Arg1:T80 Arg2:T65	
R25	treats Arg1:T62 Arg2:T65	
